Vascular Embolization Market is Estimated to Witness High Growth
Vascular Embolization Market is Estimated to Witness High Growth
The global vascular embolization market is estimated to be valued at US$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Vascular embolization devices are medical devices used to prevent or control abnormal blood loss through a blood vessel. They are used to treat several medical conditions like gastrointestinal bleeding, uterine fibroids, and arteriovenous malformations through minimally invasive procedures. Vascular embolization devices helps block blood vessels more accurately, leading to fewer repeat procedures and faster recovery times for patients.

Market Opportunity:

The opportunity in improving safety and efficacy of vascular embolization procedures is expected to drive the growth of vascular embolization market over the forecast period. Vascular embolization is a minimally invasive procedure but it requires high precision to block target blood vessels without blocking collateral ones. Advancements in technologies used in vascular embolization devices allow healthcare professionals to perform these procedures more accurately. Newer devices offer improved visibility, controllability and safety. This significantly improves clinical outcomes by reducing risks of complications and re-interventions. With continued innovations focusing on improving efficacy, safety and precision of vascular embolization procedures, the demand for advanced vascular embolization devices is likely to increase. This presents a lucrative opportunity for players in the vascular embolization market.

Porter's Analysis:

Threat of new entrants: New entrants face high capital requirements to enter the vascular embolization market as it requires extensive research and development. Strict regulatory norms also pose a barrier.

Bargaining power of buyers: Buyers have moderate bargaining power. The presence of many established players offers choice to buyers but switching costs are high due to specialized nature of equipment and techniques.

Bargaining power of suppliers: Suppliers of specialized materials and devices have moderate bargaining power given the intellectual property-based nature of products. However, diversity of suppliers mitigates the influence of individual suppliers.

Threat of new substitutes: Moderate threat as new technologies are constantly emerging but embolization techniques have proven effectiveness against alternative options.

Competitive rivalry: Intense given the presence of many global and regional players offering innovative products.

SWOT Analysis:

Strengths: Non-invasive nature and ability to treat complex conditions effectively without major surgery are key strengths.

Weaknesses: High costs associated with proprietary devices and technique training. Post-procedural care needs also increase costs.

Opportunities: Growing geriatric population and rising incidence of chronic diseases present opportunities. Emerging economies with improving healthcare infrastructure offer future scope.

Threats: Stringent regulations delay market approvals. Reimbursement barriers in some regions impede procurement.

Key Takeaways:

The Global Vascular Embolization Market Demand is expected to witness high growth over 2023-2030 fueled by increasing procedure volumes across developed regions. The global Vascular Embolization Market is estimated to be valued at US$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

North America currently dominates led by extensive research, early technology adoption, and rising prevalence of target conditions in the US and Canada. Asia Pacific is poised to be the fastest growing regional market. Presence of high unmet needs, emphasis on modernizing healthcare systems, and economical skilled labor are driving developments in countries like India and China.

Key players operating in the vascular embolization market are DyCare, Costaisa, Meditouch, Signo Motus srl, MEYTEC GmbH Informationssysteme, and Raccoon Technologies Poland LLC. They are focused on leveraging capabilities in areas like minimally invasive delivery devices, embolic agents and biocompatible materials to strengthen their market position.

Explore more information on this topic, Please visit - 

https://www.ukwebwire.com/vascular-embolization-market-size-and-trends-analysis/ 

disclaimer

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations